The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery

Phase 4 Completed 196 enrolled Hospital for Special Surgery, New York Baxter Healthcare Corporation · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effect on bleeding, it may potentially reduce the problems associated with bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood transfusion. The subject's overall participation will be over a period of 6 weeks.

Timeline

Start: 2007-10
Primary completion: 2010-08
Completion: 2010-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Floseal	Other / unclassified	—	Topical

Indications

No indication recorded.